topic: Access to Medicines

MSF challenges Gilead’s patent application for hepatitis C combination treatment in China, to bring down prices. Photo: Todd Brown
MSF challenges Gilead’s patent application for hepatitis C combination treatment in China, to bring down prices
Photo: Sandra Smiley/MSF
Universal Health Coverage: Health policies must focus on needs of individuals
MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally. Photo: Sandra Smiley/MSF
MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally
MSF approaches Delhi High Court to challenge unmerited patent grant for pneumonia vaccine
Indian patent office delivers major blow to affordable pneumonia vaccine hopes
RCEP negotiators must fix the damaging provisions that remain a threat to public health
India plays an important role in manufacturing and distributing life-saving medicines and vaccines to millions of people across the world. Photo: Giorgos Moutafis
Doctors Without Borders urges India’s Modi to remain committed to affordable medicines during White House meeting
MSF relies heavily on affordable generic medicines from India to do its medical work around the world. Photo: Guillaume Binet/MYOP
MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week
Modi’s proposed law on docs using generic name in prescriptions gets MSF vote
MSF response on upcoming RCEP negotiations in the Philippines